RTTNews | Apr 20, 2021 07:00AM EDT

06:59 Tuesday, April 20, 2021 (RTTNews.com) - Illumina, Inc. (ILMN) said it disagrees with the European Commission's Directorate-General for Competition's decision to review the company's acquisition of GRAIL. The company believes reuniting GRAIL and Illumina will bring GRAIL's breakthrough early detection multi-cancer test to patients across the world faster. Illumina noted that it will continue to work with the Directorate-General to bring the investigation to conclusion.

Francis deSouza, Chief Executive Officer of Illumina, stated: "We do not believe that the European authorities have jurisdiction to review the GRAIL acquisition and look forward to resolving this matter expeditiously."

Read the original article on RTTNews ( https://www.rttnews.com/3186327/llumina-remains-committed-to-grail-deal-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved